{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-05-20&min-answer.questionFirstAnswered.=2019-06-04T13%3A02%3A16.647Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2019-05-20&min-answer.questionFirstAnswered.=2019-06-04T13%3A02%3A16.647Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-05-20&min-answer.questionFirstAnswered.=2019-06-04T13%3A02%3A16.647Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-05-20&_page=0&min-answer.questionFirstAnswered.=2019-06-04T13%3A02%3A16.647Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-05-20&min-answer.questionFirstAnswered.=2019-06-04T13%3A02%3A16.647Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-05-20&min-answer.questionFirstAnswered.=2019-06-04T13%3A02%3A16.647Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1127411", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127411/answer", "answerText" : {"_value" : "

\u200bEducation is an integral part of the UK's approach to improving human rights. The education of girls continues to be a priority for UK development assistance in Pakistan. Under the Punjab Education Sector Programme, we are working with a local partner organisation to reintegrate young and adolescent girls who have left school prematurely back into mainstream schools or vocational education. Within less than a year, over 4000 girls have benefitted from this intervention so far.<\/p>

The British Government supports other programmes designed to improve human rights and opportunities for women, religious minorities and marginalised groups. For example, the Department for International Development's AAWAZ II programme works with communities to promote rights of children, women, youth and religious minorities, protect them from exploitation, and prevent discrimination and intolerance. It also funds interventions in support of ending child marriage.<\/p>

During my visit to Pakistan in February, I raised our concerns about child protection, the treatment of minority communities and the issue of forced marriage with Pakistan's Federal Minister for Human Rights, Dr Shireen Mazari.<\/p>

We will continue to urge the Government of Pakistan to take the steps necessary to comply in full with its human rights obligations to vulnerable groups, including religious minorities and women and girls.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"} } , "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T13:02:16.647Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pakistan: Religious Freedom"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the impact of Pakistani girls, who are members of a religious minority, being removed from schools by their parents as a result of the number of abductions and forced conversions on the literacy rate of girls in Pakistan; and what steps they intend to take to help resolve this problem.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL15822"} , {"_about" : "http://data.parliament.uk/resources/1127419", "AnsweringBody" : [{"_value" : "The Senior Deputy Speaker"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127419/answer", "answerText" : {"_value" : "

The cost of the Parliamentary Office of Science and Technology is shared by the House of Commons and the House of Lords on a 70:30 ratio. The cost to the House of Lords in each of the last five financial years is as follows:<\/p>

<\/p>

Financial Year <\/strong><\/p><\/td>

Cost<\/strong><\/p><\/td><\/tr>

2014-15<\/p><\/td>

£151,910<\/p><\/td><\/tr>

2015-16<\/p><\/td>

£172,934<\/p><\/td><\/tr>

2016-17<\/p><\/td>

£176,145<\/p><\/td><\/tr>

2017-18<\/p><\/td>

£170,345<\/p><\/td><\/tr>

2018-19<\/p><\/td>

£189,342<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4148", "label" : {"_value" : "Biography information for Lord McFall of Alcluith"} } , "answeringMemberPrinted" : {"_value" : "Lord McFall of Alcluith"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T15:15:05.91Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "204"} , "answeringDeptShortName" : {"_value" : ""} , "answeringDeptSortName" : {"_value" : "Senior Deputy Speaker (HoL)"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "POST"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask the Senior Deputy Speaker what was the cost of the Parliamentary Office of Science and Technology in each of the last five financial years for which data are available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/579", "label" : {"_value" : "Biography information for Lord Foulkes of Cumnock"} } , "tablingMemberPrinted" : [{"_value" : "Lord Foulkes of Cumnock"} ], "uin" : "HL15830"} , {"_about" : "http://data.parliament.uk/resources/1127420", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127420/answer", "answerText" : {"_value" : "

Three Royal Commissions have been established since 1989:<\/p>

<\/p>

  • Royal Commission on Criminal Justice<\/p><\/li>

  • Royal Commission on Long-term Care of the Elderly<\/p><\/li>

  • Royal Commission on Reform of the House of Lords<\/p><\/li><\/ul>

    <\/p>

    Government departments will have responded to the relevant Royal Commission reports, and those responses are a matter of public record.<\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/57", "label" : {"_value" : "Biography information for Lord Young of Cookham"} } , "answeringMemberPrinted" : {"_value" : "Lord Young of Cookham"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T14:24:30.063Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "53"} , "answeringDeptShortName" : {"_value" : "Cabinet Office"} , "answeringDeptSortName" : {"_value" : "Cabinet Office"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Royal Commissions"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government how many Royal Commissions have been established since 1989; what was the topic of each; and what recommendations of each they adopted.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/579", "label" : {"_value" : "Biography information for Lord Foulkes of Cumnock"} } , "tablingMemberPrinted" : [{"_value" : "Lord Foulkes of Cumnock"} ], "uin" : "HL15831"} , {"_about" : "http://data.parliament.uk/resources/1127421", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127421/answer", "answerText" : {"_value" : "

    The 2018 English surveillance programme for antimicrobial utilisation and resistance report contains information on carbapenem-resistant Escherichia coli (E. coli) causing bloodstream infections in England. In 2017 there were 18 cases. The number of people with other infections and carriage of E. coli resistant to carbapenems is harder to ascertain as surveillance is not as uniform.<\/p>

    Public Health England (PHE) publishes guidance on the prevention and control of carbapenemase-producing Enterobacteriaceae (including E. coli); guidance is available for both acute and non-acute settings, copies of the Toolkit for managing carbapenemase-producing Enterobacteriaceae in non-acute and community settings<\/em> and Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae<\/em> are attached. PHE is supporting actions outlined in the United Kingdom\u2019s Tackling Antimicrobial Resistance National Action Plan that aim to prevent and control the transmission of carbapenem-resistant bacteria, which includes reducing the number of specific drug-resistant infections in people by 10% by 2025; reducing UK antimicrobial use in humans by 15% by 2024; and adding carbapenem-resistant Gram-negative infections to the list of notifiable diseases in existing laboratory reporting systems.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "attachment" : [{"_about" : "http://data.parliament.uk/resources/1127421/answer/attachment/1", "fileName" : {"_value" : "Acute_trust_toolkit_for_the_early_detection.pdf"} , "title" : "Acute trust toolkit"} , {"_about" : "http://data.parliament.uk/resources/1127421/answer/attachment/2", "fileName" : {"_value" : "CPE-Non-AcuteToolkit_CORE.pdf"} , "title" : "CPE Non Acute toolkit"} ], "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T13:45:10.523Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bacterial Diseases"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 14 May (HL15384), what assessment they have made of the number of people, with or without resistant blood stream infections, who have Carbapenem resistant E. coli-like bacteria present in their bodies; and what (1) proposed, and (2) current, initiatives there are to control the transmission of such bacteria.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3596", "label" : {"_value" : "Biography information for Baroness Gardner of Parkes"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Gardner of Parkes"} ], "uin" : "HL15832"} , {"_about" : "http://data.parliament.uk/resources/1127422", "AnsweringBody" : [{"_value" : "Northern Ireland Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127422/answer", "answerText" : {"_value" : "

    This is an important issue which the UK Government takes seriously. We received advice from the Victims Commissioner on Friday 31 May 2019 - the completion of this advice represents an important step forward. We are carefully considering that advice and possible next steps, which we aim to set out shortly.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4686", "label" : {"_value" : "Biography information for Lord Duncan of Springbank"} } , "answeringMemberPrinted" : {"_value" : "Lord Duncan of Springbank"} , "dateOfAnswer" : {"_value" : "2019-06-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-07T10:01:46.01Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "21"} , "answeringDeptShortName" : {"_value" : "Northern Ireland"} , "answeringDeptSortName" : {"_value" : "Northern Ireland"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Terrorism: Northern Ireland"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government when they will legislate to provide a pension for severely injured victims of The Troubles in Northern Ireland represented by the Wave Trauma Action Group.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/567", "label" : {"_value" : "Biography information for Lord Hain"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hain"} ], "uin" : "HL15833"} , {"_about" : "http://data.parliament.uk/resources/1127424", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127424/answer", "answerText" : {"_value" : "

    We are informed by NHS England that its joint Public Health England funded Sustainable Development Unit (SDU) has reviewed a scheme operated by GlaxoSmithKline that encourages return of inhalers for recycling. The scheme is very welcome but limited in scope, currently recovering around 1% of all inhalers.<\/p>

    All used inhalers can already be returned to all pharmacies to be disposed of by incineration with the medicines waste streams.<\/p>

    NHS England has invited industry suggestions to the national Low Carbon Inhalers Working Group established by the SDU, on ways to increase recovery for environmentally safe disposal and recycling.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T13:46:45.69Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Lung Diseases: Medical Equipment"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the potential of schemes by pharmaceutical companies to develop recycling and recovery schemes for respiratory inhalers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL15835"} , {"_about" : "http://data.parliament.uk/resources/1127426", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127426/answer", "answerText" : {"_value" : "

    We have made no such assessment on the proportion of the National Health Service carbon footprint made by hydrofluorocarbon in metred dose inhalers or of the impact of the use of metred dose inhalers containing hydrofluorocarbons in releasing greenhouse gases. However, we are informed by NHS England that the National Atmospheric Emissions Inventory calculated the carbon emissions from inhalers in England as 850,000 tonnes of carbon dioxide equivalents. This is equivalent to approximately 4% of the entire carbon footprint of the NHS in England.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL15840"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T13:46:09.397Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Lung Diseases: Medical Equipment"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the impact of the use of metred dose inflators containing hydrofluorocarbons in releasing greenhouse gases.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL15837"} , {"_about" : "http://data.parliament.uk/resources/1127427", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127427/answer", "answerText" : {"_value" : "

    NHS England has been in regular dialogue with industry over the last 18 months about the need to reduce the environmental damage caused by asthma inhalers. As a result, an industry working group on this has been formed, chaired by the Industry Pharmaceutical Aerosol Consortium (IPAC). IPAC has now accepted an invitation to join the national Low Carbon Inhalers Working Group, chaired by the Sustainable Development Unit, to represent industry. This working group has been asked to provide proposals from industry on reducing the carbon impacts of inhalers to support the NHS Long Term Plan target.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T13:39:39.5Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Asthma: Medical Equipment"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what discussions they intend to have, if any, with pharmaceutical companies about how the environmental damage caused by asthma inhalers may be reduced.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL15838"} , {"_about" : "http://data.parliament.uk/resources/1127428", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127428/answer", "answerText" : {"_value" : "

    The National Institute for Health and Care Excellence (NICE) published an online only patient decision aid for inhalers used in the treatment of asthma on 8 April 2019.<\/p>

    The purpose of this aid is to help people with asthma and their healthcare professional to discuss the different inhaler devices that are available to treat their condition and where appropriate, to consider the environmental impact of the inhaler. The patient decision aid has been downloaded over 1,500 times since its publication.<\/p>

    To encourage use of the decision aid, NICE is contributing to an expert working group on sustainable inhalers led by the Sustainable Development Unit which is actively promoting this work. The working group members include clinicians and patient organisations, such as Asthma UK and the British Lung Foundation. NICE has also shared the patient decision aid through its network of NICE associates - a network of National Health Service professionals who support implementation of NICE guidance across the NHS.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T13:42:39.77Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Asthma: Medical Equipment"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the sufficiency of the progress made by NICE on working with clinicians and industry to promote greater use of asthma inhalers with low global warming potential.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL15839"} , {"_about" : "http://data.parliament.uk/resources/1127429", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1127429/answer", "answerText" : {"_value" : "

    We have made no such assessment on the proportion of the National Health Service carbon footprint made by hydrofluorocarbon in metred dose inhalers or of the impact of the use of metred dose inhalers containing hydrofluorocarbons in releasing greenhouse gases. However, we are informed by NHS England that the National Atmospheric Emissions Inventory calculated the carbon emissions from inhalers in England as 850,000 tonnes of carbon dioxide equivalents. This is equivalent to approximately 4% of the entire carbon footprint of the NHS in England.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-06-04", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL15837"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-04T13:46:09.343Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Lung Diseases: Medical Equipment"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the proportion of the NHS carbon footprint made by hydrofluorocarbon in metred dose inflators.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL15840"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-05-20&_page=1&min-answer.questionFirstAnswered.=2019-06-04T13%3A02%3A16.647Z", "page" : 0, "startIndex" : 1, "totalResults" : 33, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }